Holen Sie sich die Stockscreener-App
34.94
1.83%
-0.6209
Schlusskurs vom Vortag:
$35.56
Offen:
$35.97
24-Stunden-Volumen:
10.28M
Relative Volume:
0.43
Marktkapitalisierung:
$7.95B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
50.64
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-3.70%
1M Leistung:
+0.58%
6M Leistung:
-45.64%
1J Leistung:
+33.24%
1-Tages-Spanne:
$34.87
$36.27
1-Wochen-Bereich:
$34.31
$37.61
52-Wochen-Spanne:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
34.94 | 8.10B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
123.73 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.11 | 47.07B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.9401 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.14 | 34.82B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
514.19 | 22.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Texas Permanent School Fund Corp Invests $2.57 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
(HIMS) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Best Healthcare Stocks Worth WatchingDecember 18th - MarketBeat
Is Hims & Hers Health’s US$200 Million Ohio Bet Quietly Redefining Its Core Strategy (HIMS)? - Yahoo Finance
2 Top Stocks to Buy With $500 Right Now - Yahoo Finance
Key Financial Officer’s Major Stock Sale Raises Questions at Hims & Hers - AD HOC NEWS
Insider Sell: Michael Chi Sells 13,750 Shares of Hims & Hers Hea - GuruFocus
Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 8,411 Shares of Stock - MarketBeat
Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells 7,054 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Sells $367,870.91 in Stock - MarketBeat
Hims & Hers Health Insider Sold Shares Worth $308,768, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Insider Sold Shares Worth $367,871, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Insider Sold Shares Worth $258,952, According to a Recent SEC Filing - marketscreener.com
Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026 - TradingView — Track All Markets
Digital health giant Hims & Hers invests $200 million to expand Ohio life sciences hub - Ohio Tech News
Telehealth company Hims & Hers investing $200 million in New Albany - The Columbus Dispatch
Hims & Hers to invest $200M in New Albany expansion, create 400 jobs - The Business Journals
COO Chi Files To Sell 13,750 Of Hims & Hers Health Inc [HIMS] - TradingView — Track All Markets
Hamilton Lane Advisors LLC Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Leadership Executes Planned Stock Transactions - AD HOC NEWS
Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90‑Day Pullback - Yahoo Finance
Hims & Hers Scales Technology-Driven Care as Profitability Evolves - Yahoo Finance
Healthcare Stocks To Keep An Eye OnDecember 15th - MarketBeat
Hims & Hers Health, Inc. $HIMS Holdings Raised by Nomura Holdings Inc. - MarketBeat
Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership [Video] - AOL.com
Castleark Management LLC Invests $2.92 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Marex Group plc Invests $53.63 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Q3 Earnings and Regulatory Challenges - Quiver Quantitative
Biomarker Testing Experiences - Trend Hunter
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know - sharewise.com
Hims & Hers Expands Weight-Management Program to the United Kingdom - Finviz
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell? - MSN
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
Why Novo Nordisk Stock Topped the Market on Thursday - AOL.com
Hims & Hers targets UK’s weight loss market - eMarketer
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Hims & Hers Health's Options: A Look at What the Big Money is Thinking - Benzinga
Insider Sell Alert: Perez Garcia Andrea G Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health (NYSE:HIMS) Director Garcia Andrea Perez Sells 2,500 Shares of Stock - MarketBeat
Hims stock falls after lawmakers propose GLP-1 compounding restrictions By Investing.com - Investing.com Nigeria
Hims stock falls after lawmakers propose GLP-1 compounding restrictions - Investing.com
High Short-Interest Stocks to Buy Before Q1 2026 - Investing.com
Hims & Hers launches weight-loss business in UK - pharmaphorum
Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? - Finviz
Hims & Hers Health (NYSE:HIMS) Earns Overweight Rating from Analysts at Barclays - MarketBeat
Hims & Hers Expands Weight Loss Program to the U.K. - Yahoo Finance
Hims & Hers (HIMS) Expands Weight Loss Program to the UK - GuruFocus
HIMS Expands Weight Loss Program to the UK - GuruFocus
Hims & Hers brings weight loss program to the U.K. (HIMS:NYSE) - Seeking Alpha
Hims and Hers to offer weight-loss treatments in UK - The Mighty 790 KFGO
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
11.81%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):